Predictive Factors for Local Recurrence in Breast Cancer
Authors:
- Paula H.M. ElkhuizenPEPaula H.M. Elkhuizen
- Harry BartelinkHBHarry Bartelink
- Marc J. van de VijverMVMarc J. van de Vijver
- 1 April 2012
- journal article
- review article
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 22 (2) , 100-107
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Trial Assessing Individualized Options for Treatment for Breast Cancer: The TAILORx TrialFuture Oncology, 2008
- The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation studyBreast Cancer Research and Treatment, 2008
- Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 TrialJournal of Clinical Oncology, 2007
- The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer CellsNew England Journal of Medicine, 2007
- Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast CancerJNCI: Journal of the National Cancer Institute, 2006
- Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancerThe Lancet, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002